Live feed
·
INSIDERFiling
Halozyme Therapeutics Inc. logo

SVP, CHIEF FINANCIAL OFFICER Labrosse Nicole converted options into 12,020 shares and covered exercise/tax liability with 6,484 shares, increasing direct ownership by 17% to 38,494 units (SEC Form 4)